Literature DB >> 2889121

Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems.

B H Westerink1, G Damsma, H Rollema, J B De Vries, A S Horn.   

Abstract

Brain dialysis is rapidly becoming a routine research method with a wide range of applications. Since 1982 this sampling technique is frequently used as a method to study the in vivo release of endogenous neurotransmitters such as dopamine, noradrenaline, serotonin, acetylcholine and certain amino acids. In this review most of the studies that have appeared in this field, are evaluated. Special attention was given to the question whether the neurotransmitter content in the dialysate is related to neurotransmission. Criteria such as the presence of a high tissue/dialysate concentration ratio, the sensitivity of the transmitters to membrane active compounds and the occurrence of receptor-mediated effects, are discussed. It is concluded that dopamine, noradrenaline and acetylcholine found in the dialysate are directly derived from neurotransmission, whereas the overflow of excitatory amino acid neurotransmitters is related to neurogenic as well as to metabolic events.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889121     DOI: 10.1016/0024-3205(87)90695-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  52 in total

1.  Social context-dependent singing-regulated dopamine.

Authors:  Aya Sasaki; Tatyana D Sotnikova; Raul R Gainetdinov; Erich D Jarvis
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

2.  Overview of microdialysis.

Authors:  T S Shippenberg; A C Thompson
Journal:  Curr Protoc Neurosci       Date:  2001-05

3.  Dopaminergic regulation of striatal cholinergic interneurons: an in vivo microdialysis study.

Authors:  G Damsma; P de Boer; B H Westerink; H C Fibiger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

4.  Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex.

Authors:  J Semba; M Doheny; P N Patsalos; G Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 5.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats.

Authors:  M Ruotsalainen; M Heikkilä; P Lillsunde; T Seppälä; L Ahtee
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.

Authors:  A Colzi; F d'Agostini; A M Cesura; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.

Authors:  M Santiago; A Machado; J Cano
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.

Authors:  A J Dekker; L J Thal
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

10.  Increase in dopamine release from the nucleus accumbens in response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain.

Authors:  B H Westerink; A Teisman; J B de Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.